Connect Biopharma Holdings Limited Common Stock, Capital Shares Reserved for Future Issuance
Connect Biopharma Holdings Limited (CNTB) had Common Stock, Capital Shares Reserved for Future Issuance of 19.73 million shares as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2025-03-31
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 19.73M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2024-12-31 | 19.73M shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |